Thursday, September 24, 2020

Cipla gets final nod from USFDA for multiple sclerosis drug

Cipla gets final nod from USFDA for multiple sclerosis drug The newly approved product is a generic therapeutic equivalent version of Biogen IDEC Inc#39;#39;s Tecfidera.

from Moneycontrol Business News https://ift.tt/32ZecRt

No comments:

Post a Comment

European shares log weekly losses on Iran war-linked inflation woesdrop

European markets experienced a significant downturn, with the STOXX 600 index sliding due to escalating energy inflation fears stemming from...